Search for Clinical Trial Results

Sponsored By

Osteogenesis Imperfecta Type III - 7 Studies Found

Status Study
Completed Study Name: Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta
Condition:
  • Osteogenesis Imperfecta Type II
  • Osteogenesis Imperfecta Type III Date: 2010-02-01
    Interventions: Biological: Mesenchymal Stromal Cells Both cohorts will receive multiple infusions of ex-vivo expanded M
Completed Study Name: An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta
Condition: Osteogenesis Imperfecta
Date: 2009-09-21
Interventions: Drug: Zoledronic Acid Each patient is to receive an initial dose of zoledronic acid of 0.0125 mg per kg
Recruiting Study Name: A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804
Condition:
  • Osteogenesis Imperfecta, Type I
  • Osteogenesis Imperfecta Type III Date: 2017-04-03
    Interventions:
    • Drug: BPS804 Intravenous infus
Completed Study Name: Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
Condition: Osteogenesis Imperfecta
Date: 2005-08-15
Interventions: Drug: Zoledronic Acid
Completed Study Name: Growth Hormone Therapy in Osteogenesis Imperfecta
Condition: Osteogenesis Imperfecta
Date: 1999-11-03
Interventions:
  • Drug: Humatrope Patients recei
Completed Study Name: Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation
Condition: Osteogenesis Imperfecta
Date: 2008-06-23
Interventions:
  • Other: Bone Marrow Cell Transplantation
  • Ra
Not yet recruiting Study Name: Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta
Condition: Osteogenesis Imperfecta
Date: 2016-10-13
Interventions: Drug: Fresolimumab The purpose of this study is to determine if fresolimumab is safe as a treatment for